Literature DB >> 23144074

COL4A5-associated X-linked Alport syndrome in a female patient with early inner ear deafness due to a mutation in MYH9.

Katja Strasser1, Julia Hoefele, Carsten Bergmann, Anja K Büscher, Rainer Büscher, Peter F Hoyer, Stefanie Weber.   

Abstract

Alport syndrome (ATS) is a type-IV collagen inherited disorder, caused by mutations in COL4A3 and COL4A4 (autosomal recessive) or COL4A5 (X-linked). Clinical symptoms include progressive renal disease, eye abnormalities and high-tone sensorineural deafness. A renal histology very similar to ATS is observed in a subset of patients affected by mutations in MYH9, encoding non-muscle-myosin Type IIa--a cytoskeletal contractile protein. MYH9-associated disorders (May-Hegglin anomaly, Epstein and Fechtner syndrome, and others) are inherited in an autosomal dominant manner and characterized by defects in different organs (including eyes, ears, kidneys and thrombocytes). We describe here a 6-year-old girl with haematuria, proteinuria, and early sensorineural hearing loss. The father of the patient is affected by ATS, the mother by isolated inner ear deafness. Genetic testing revealed a pathogenic mutation in COL4A5 (c.2605G>A) in the girl and her father and a heterozygous mutation in MYH9 (c.4952T>G) in the girl and her mother. The paternal COL4A5 mutation seems to account for the complete phenotype of ATS in the father and the maternal mutation in MYH9 for the inner ear deafness in the mother. It has been discussed that the interaction of both mutations could be responsible for both the unexpected severity of ATS symptoms and the very early onset of inner ear deafness in the girl.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23144074     DOI: 10.1093/ndt/gfs468

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Heterozygous Urinary Abnormality-Causing Variants of COL4A3 and COL4A4 Affect Severity of Autosomal Recessive Alport Syndrome.

Authors:  Tomoko Horinouchi; Tomohiko Yamamura; China Nagano; Nana Sakakibara; Shinya Ishiko; Yuya Aoto; Rini Rossanti; Koichi Nakanishi; Yuko Shima; Naoya Morisada; Kazumoto Iijima; Kandai Nozu
Journal:  Kidney360       Date:  2020-07-16

2.  Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.

Authors:  Naohiro Kamiyoshi; Kandai Nozu; Xue Jun Fu; Naoya Morisada; Yoshimi Nozu; Ming Juan Ye; Aya Imafuku; Kenichiro Miura; Tomohiko Yamamura; Shogo Minamikawa; Akemi Shono; Takeshi Ninchoji; Ichiro Morioka; Koichi Nakanishi; Norishige Yoshikawa; Hiroshi Kaito; Kazumoto Iijima
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-08       Impact factor: 8.237

3.  Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome.

Authors:  Tomohiko Yamamura; Kandai Nozu; Xue Jun Fu; Yoshimi Nozu; Ming Juan Ye; Akemi Shono; Satoko Yamanouchi; Shogo Minamikawa; Naoya Morisada; Koichi Nakanishi; Yuko Shima; Norishige Yoshikawa; Takeshi Ninchoji; Ichiro Morioka; Hiroshi Kaito; Kazumoto Iijima
Journal:  Kidney Int Rep       Date:  2017-05-04

4.  A novel frameshift mutation of COL4A5 in a Chinese family with presumed IgA nephropathy and chronic glomerulonephritis.

Authors:  Qian Zhu; Cong Zhou; Jing Wang
Journal:  J Clin Lab Anal       Date:  2020-09-06       Impact factor: 3.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.